Scientists test if timing of radiation boosts cancer treatment
NCT ID NCT03223155
Summary
This study is testing the safety of combining two immunotherapy drugs (nivolumab and ipilimumab) with a precise form of radiation (SBRT) for people with advanced non-small cell lung cancer that has spread. The main goal is to find the safest dose of radiation for different body areas when given with these drugs. Researchers are also comparing whether giving the radiation at the same time as the drugs or one after the other works better and causes fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.